Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system

Open-access database of literature derived drug-related Torsade de Pointes cases

(2022) Laura Krumpholz et al.   BMC Pharmacology & Toxicology

Recommendations on off‐label use of intravenous azithromycin in children

(2021) Pengxiang Zhou et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections

(2021) Ruwen Böhm et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

(2021) Robert L. Findling et al.   CNS DRUGS

Drug-induced QT Prolongation Atlas (DIQTA) for enhancing cardiotoxicity management

(2021) Shihai Li et al.   DRUG DISCOVERY TODAY

Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations

(2020) Ola Caster et al.   DRUG SAFETY

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association

(2020) James E. Tisdale et al.   CIRCULATION

Effect of age and gender on the QTc-interval in healthy individuals and patients with long-QT syndrome

(2018) Arja Suzanne Vink et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Sex-related Differences in Drug-induced QT Prolongation and Torsades de Pointes: a New Model System with Human iPSC-CMs

(2018) Jianhua Huo et al.   TOXICOLOGICAL SCIENCES

Prevalence of Torsades de Pointes inducing drugs usage among elderly outpatients in North Jordan Hospitals

(2018) Ahmad Al-Azayzih et al.   SAUDI PHARMACEUTICAL JOURNAL

Incidence of Torsade de Pointes in a tertiary hospital population

(2017) Eline Vandael et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Use of data mining at the Food and Drug Administration

(2015) Hesha J Duggirala et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe

(2015) Elisabetta Poluzzi et al.   PLoS One

QT interval prolongation and the risk of torsades de pointes: essentials for clinicians

(2013) Katy E. Trinkley et al.   CURRENT MEDICAL RESEARCH AND OPINION

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

(2013) Elisabetta Poluzzi et al.   DRUG SAFETY

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?

(2012) Rashmi R. Shah   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

OpenVigil—free eyeballs on AERS pharmacovigilance data

(2012) Ruwen Böhm et al.   NATURE BIOTECHNOLOGY

Selected control events and reporting odds ratio in signal detection methodology

(2010) Nobuhiro Ooba et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance

(2009) B Darpo   BRITISH JOURNAL OF PHARMACOLOGY

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)

(2009) Elisabetta Poluzzi et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY